Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biological Chemistry

Nanobacteria May Only Be Nanoparticles

April 7, 2008 | A version of this story appeared in Volume 86, Issue 14

[+]Enlarge
Credit: © Proc. Natl. Acad. Sci. USA
Credit: © Proc. Natl. Acad. Sci. USA

Nanobacteria are a putative novel life form first identified in the 1990s and implicated in the origin of life and in a variety of diseases. Now it seems that nanobacteria may simply be calcium carbonate nanoparticles, according to research by Jan Martel of Chang Gung University, in Taiwan, and John Ding-E Young of Rockefeller University (Proc. Natl. Acad. Sci. USA, DOI: 10.1073/pnas.0711744105). Martel and Young used published methods to "culture" nanobacteria from human blood and compared the resulting nanospheres to calcium compounds likely to precipitate in biological fluids. They found that calcium carbonate nanoparticles (shown) prepared in cell culture media from (NH4)2CO3 and CaCl2 closely resemble previously reported isolated nanobacteria. Specifically, the CaCO3 nanoparticles appear to have an amorphous layer at the surface that looks like a membrane, and two adjacent particles seem to be undergoing cell division. The researchers also found that purported nanobacteria-specific antibodies, which are commercially available, may bind to serum albumin and form an insoluble matrix with CaCO3. Before now, CaCO3 particles had only been identified in the inner ear, so finding them in other tissues such as blood may have implications for disease pathology.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.